Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1
Authors:
Open Access
- 2 August 2024
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 43 (8) , 114567
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humansImmunity, 2024
- Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variantsCell, 2024
- Evolution of the SARS-CoV-2 Omicron spikeCell Reports, 2023
- Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunityCell Reports, 2023
- The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infectionCell, 2023
- Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmissionReviews in Medical Virology, 2022
- Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variantsCell, 2022
- Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationCell, 2022
- Immune imprinting and SARS-CoV-2 vaccine designTrends in Immunology, 2021
- N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Cell, 2021